Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
eHealth
EHTH
$39.4M
| $10.6M | 0.01% |
878,900
+89,400
| +11% | +$1.03M |
|
1202
Ribbon Communications
RBBN
$379M
| $10.6M | 0.01% |
1,603,900
-179,600
| -10% | -$1.14M |
|
|
SEMG
1203
DELISTED
SEMGROUP CORPORATION
SEMG
| $10.6M | 0.01% |
293,557
+173,000
| +144% | +$6.58M |
|
|
CBM
1204
DELISTED
Cambrex Corporation
CBM
| $10.6M | 0.01% |
+191,800
| New | +$10.2M |
|
|
LSXMA
1205
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $10.6M | 0.01% |
+375,240
| New | +$10.1M |
|
|
MLNX
1206
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $10.5M | 0.01% |
206,800
-511,583
| -71% | -$24.3M |
|
1207
Nathan's Famous
NATH
$398M
| $10.5M | 0.01% |
167,900
+5,100
| +3% | +$315K |
|
|
UCFC
1208
DELISTED
United Community Financial Corp
UCFC
| $10.5M | 0.01% |
1,261,304
+107,986
| +9% | +$927K |
|
1209
NNN REIT
NNN
$8.87B
| $10.5M | 0.01% |
241,100
-247,400
| -51% | -$10.9M |
|
1210
Trade Desk
TTD
$6.49B
| $10.5M | 0.01% |
+2,822,000
| New | +$9.66M |
|
1211
Hovnanian Enterprises
HOV
$800M
| $10.5M | 0.01% |
185,016
+88,556
| +92% | +$5.23M |
|
1212
KRONOS Worldwide
KRO
$963M
| $10.5M | 0.01% |
637,900
-9,200
| -1% | -$128K |
|
1213
TD Synnex
SNX
$20.6B
| $10.5M | 0.01% |
187,200
+81,600
| +77% | +$4.86M |
|
|
TWO
1214
Two Harbors Investment
TWO
$1.26B
| $10.5M | 0.01% |
136,550
-170,988
| -56% | -$12.5M |
|
|
JCP
1215
DELISTED
J.C. Penney Company, Inc.
JCP
| $10.5M | 0.01% |
1,699,100
-9,125,900
| -84% | -$60.3M |
|
1216
Steel Dynamics
STLD
$37.6B
| $10.4M | 0.01% |
299,700
-2,006,500
| -87% | -$71.5M |
|
|
MRC
1217
DELISTED
MRC Global
MRC
| $10.4M | 0.01% |
566,700
-679,300
| -55% | -$13.5M |
|
1218
ITT
ITT
$19.2B
| $10.4M | 0.01% |
+253,200
| New | +$10.4M |
|
1219
CRH
CRH
$65.3B
| $10.4M | 0.01% |
295,100
+132,100
| +81% | +$4.6M |
|
|
NTL
1220
DELISTED
Nortel Invesora 1/20 Ser B Shr
NTL
| $10.4M | 0.01% |
398,900
-16,400
| -4% | -$411K |
|
1221
Realty Income
O
$59.8B
| $10.4M | 0.01% |
179,568
-1,036,818
| -85% | -$60M |
|
|
KYNB
1222
Kyntra Bio
KYNB
$28.7M
| $10.4M | 0.01% |
16,804
+3,500
| +26% | +$2.13M |
|
1223
Celestica
CLS
$45.8B
| $10.3M | 0.01% |
708,788
+33,823
| +5% | +$452K |
|
1224
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.1B
| $10.3M | 0.01% |
424,000
-30,400
| -7% | -$655K |
|
1225
Jack Henry & Associates
JKHY
$10.8B
| $10.3M | 0.01% |
110,400
-51,119
| -32% | -$4.71M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.